95 filings
Page 4 of 5
8-K
3rvbi2y09zi4ntu3
4 Mar 21
Avita Medical, Inc. Announces Closing of Offering of 3,214,250 Shares of Common Stock
11:16am
8-K
pmvg6 5lgm5i
1 Mar 21
Avita Medical, Inc. Announces Pricing of Its Public Offering of
4:05pm
8-K
49g59udnietz7034
12 Jan 21
AVITA Medical Announces Preliminary Fiscal Second Quarter 2021 Results
10:50am
8-K
r05kiezl
2 Dec 20
Amendments to Articles of Incorporation or Bylaws
3:33pm
8-K
1gd qhggq4pcrkafj
2 Dec 20
AVITA Therapeutics Appoints Kathy McGee as Chief Operating Officer
11:01am
8-K
q8j0kwwqp
12 Nov 20
Submission of Matters to a Vote of Security Holders
10:05am
8-K
gu1hs1mh2ba67
10 Nov 20
Other Events
10:45am
8-K
h31pq
6 Nov 20
AVITA Therapeutics, Inc. Announces Executive Change
6:06am
8-K
cl81ic0bkfihtc ru5l
4 Nov 20
Avita Therapeutics, Inc. Announces Correction of Time for the 2020 Annual Stockholder Meeting
10:00pm
8-K
akt3aak9btro
2 Nov 20
AVITA Therapeutics, Inc. Announces Adjournment of 2020 Annual Stockholder Meeting
10:04am
8-K
321duir4 tke
13 Oct 20
Shelf Registration Statement Filed with SEC
10:36am
8-K
cy6vkbf4v55hophmv4g
10 Sep 20
Departure of Directors or Certain Officers
10:27am
8-K
zhvp2wnq 8xb
31 Aug 20
Preliminary Final Report
10:12am
8-K
hfh7k9vnb3gp43 fl
28 Aug 20
AVITA Therapeutics Provides Company Update
11:47am
8-K
i4vb8f
4 Aug 20
Departure of Directors or Certain Officers
8:46am
8-K
62lzxow
13 Jul 20
BARDA to Initiate Procurement of the RECELLĀ® System for Emergency Response Preparedness
6:08am
8-K
20pg cwhman30
9 Jul 20
AVITA Therapeutics Provides Company Update and Preliminary Unaudited
9:41am
8-K
zthif5kevhap2cohhf
6 Jul 20
Changes in Registrant's Certifying Accountant
3:20pm
6-K
upgp1p
22 Jun 20
Current report (foreign)
3:28pm
6-K
vb6om mlfoh
15 Jun 20
Current report (foreign)
4:17pm